Project 1: The Molecular Basis For Alterations in GABA-Mediated network Oscillati

项目 1:GABA 介导的网络振荡改变的分子基础

基本信息

  • 批准号:
    8105261
  • 负责人:
  • 金额:
    $ 100.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-01 至 2013-06-30
  • 项目状态:
    已结题

项目摘要

The central hypothesis of this Center posits that a distinctive pattern of molecular alterations in subsets of GABA neurons gives rise to disturbances in cortical network oscillations that underlie the information processing deficits of schizophrenia. Disturbances in markers of cortical GABA neurotransmission are common in schizophrenia and are most prominent in two types of GABA neurons: parvalbumin-positive (PV), fast-spiking neurons and somatostatin-positive (SST), low-threshold spiking neurons. PV and SST cells each form networks with neurons of the same type that are thought to play central roles in the generation of gamma (30-80 Hz) and theta (4-7 Hz) oscillations, respectively, both of which are disturbed in subjects with schizophrenia. Network oscillations depend, at least in part, on 3 physiological properties: 1) the strength [i.e., inhibitory post-synaptic current (IPSC) amplitude] of GABA neurotransmission as determined by both pre- and post-synaptic factors; 2) the kinetics (i.e., IPSC duration) of GABA neurotransmission as determined principally by the subunit composition of post-synaptic GABA-A receptors; and 3) the nature of the resulting inhibition (i.e., shunting or hyperpolarizing) as determined by chloride ion flow when GABA-A receptors are activated. Each of these physiological features is, in turn, dependent upon the expression of particular sets of gene products. Consequently, we hypothesize that the alterations in gamma and theta oscillations in schizophrenia reflect cell type-specific disturbances in the gene products that influence the strength, kinetics or nature of GABA-mediated inhibition. Studies in postmortem human brain, using the dorsolateral prefrontal cortex (DLPFC) as a prototypic cortical region affected in schizophrenia, will be conducted to determine if 1) the presynaptic strength of GABA neurotransmission in schizophrenia is impaired due to deficits in the amount of GAD67 protein available to synthesize GABA in PV and SST neurons; 2) if cell type-specific alterations in the expression of a1 and a2 GABA-A receptor subunits disrupt the kinetics of GABA neurotransmission in schizophrenia; and 3) if shifts in the expression of chloride transporters in schizophrenia disrupt the shunting inhibitory input to GABA neurons and/or the hyperpolarizing inhibitory input to pyramidal cells required for robust oscillations. The proposed studies are both methodologically and conceptually innovative, and these investigations depend upon and inform the studies proposed in other projects in this Center. Thus, the outcomes of the proposed studies are likely to be highly informative regarding both the disease mechanisms underlying oscillatory and information processing deficits in schizophrenia and in identifying novel molecular targets for treating these deficits.
该中心的核心假设假定,在细胞亚群中, GABA神经元引起的干扰皮层网络振荡的基础信息 精神分裂症的处理缺陷皮质GABA神经传递标志物的紊乱是 常见于精神分裂症中,并且在两种类型的GABA神经元中最突出:小清蛋白阳性(PV), 快速发放神经元和生长抑素阳性(SST)低阈值发放神经元。PV和SST电池各 与被认为在产生神经元中起核心作用的相同类型的神经元形成网络。 γ(30-80 Hz)和θ(4-7 Hz)振荡,这两种振荡在患有 精神分裂症网络振荡至少部分取决于3个生理特性:1)强度 [i.e.,抑制性突触后电流(IPSC)振幅]的GABA神经传递,由两个 突触前和突触后因子; 2)动力学(即,IPSC持续时间)的GABA神经传递, 主要由突触后GABA-A受体的亚基组成决定;和3) 得到的抑制(即,当GABA-A 受体被激活。这些生理特征中的每一个反过来又取决于 特定的基因产物。因此,我们假设伽马和θ的改变 精神分裂症中的振荡反映了基因产物中细胞类型特异性的干扰, GABA介导的抑制的强度、动力学或性质。在死后人脑的研究中,使用 背外侧前额叶皮层(DLPFC)作为精神分裂症中受影响的原型皮层区域,将被 进行以确定1)精神分裂症中GABA神经传递的突触前强度是否 由于PV和SST中可用于合成GABA的GAD 67蛋白量不足而受损 2)如果细胞类型特异性改变α 1和α 2 GABA-A受体亚单位的表达, 精神分裂症中GABA神经传递的动力学;以及3)如果氯的表达发生变化, 精神分裂症中的转运蛋白破坏了对GABA神经元的分流抑制性输入和/或 对锥体细胞的超极化抑制性输入是产生强振荡所必需的。拟议的研究是 无论是方法上和概念上的创新,这些调查依赖于并告知 本中心其他项目中提出的研究。因此,拟议研究的结果可能是 关于振荡和信息处理的疾病机制的高度信息 精神分裂症的缺陷和识别治疗这些缺陷的新分子靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David A Lewis其他文献

Tyrosine Hydroxylase- and Dopamine Transporter-Immunoreactive Axons in the Primate Cerebellum
灵长类小脑内酪氨酸羟化酶和多巴胺转运体免疫反应性轴突
  • DOI:
    10.1016/s0893-133x(99)00139-6
  • 发表时间:
    2000-05-01
  • 期刊:
  • 影响因子:
    7.100
  • 作者:
    Darlene S Melchitzky;David A Lewis
  • 通讯作者:
    David A Lewis
Antimicrobial susceptibility assays for emNeisseria gonorrhoeae/em: a proof-of-principle population-based retrospective analysis
淋病奈瑟菌的抗菌药物敏感性试验:一项基于人群的原理验证回顾性分析
  • DOI:
    10.1016/s2666-5247(23)00071-x
  • 发表时间:
    2023-07-01
  • 期刊:
  • 影响因子:
    20.400
  • 作者:
    Sara F E Bell;Robert S Ware;David A Lewis;Monica M Lahra;David M Whiley
  • 通讯作者:
    David M Whiley
The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinohilia and systemic symptoms in relation to the eliciting drug.
药物引起的过敏综合征/药疹的临床表现多种多样,伴有嗜酸性粒细胞增多和与诱发药物相关的全身症状。
Contraindications to pharmacologic therapies for gout.
痛风药物治疗的禁忌症。
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    5.9
  • 作者:
    David A Lewis;W. Herrington
  • 通讯作者:
    W. Herrington
統合失調症の組織病理所見-前頭前野ニューロンの変化とその病態生理
精神分裂症的组织病理学发现——前额皮质神经元的变化及其病理生理学
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    橋本隆紀;David A Lewis
  • 通讯作者:
    David A Lewis

David A Lewis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David A Lewis', 18)}}的其他基金

Cortical Cells Circuits Connectivity and Cognition in Schizophrenia
精神分裂症的皮层细胞回路连接和认知
  • 批准号:
    8666277
  • 财政年份:
    2014
  • 资助金额:
    $ 100.05万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    9355831
  • 财政年份:
    2014
  • 资助金额:
    $ 100.05万
  • 项目类别:
Cortical Cells Circuits Connectivity and Cognition in Schizophrenia
精神分裂症的皮层细胞回路连接和认知
  • 批准号:
    9242722
  • 财政年份:
    2014
  • 资助金额:
    $ 100.05万
  • 项目类别:
Cortical Cells Circuits Connectivity and Cognition in Schizophrenia
精神分裂症的皮层细胞回路连接和认知
  • 批准号:
    9461607
  • 财政年份:
    2014
  • 资助金额:
    $ 100.05万
  • 项目类别:
Intrinsic Properties of Cortical Layer 3 Pyramidal Cells in Monkeys
猴子皮质第 3 层锥体细胞的内在特性
  • 批准号:
    9355828
  • 财政年份:
    2014
  • 资助金额:
    $ 100.05万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    9355824
  • 财政年份:
    2014
  • 资助金额:
    $ 100.05万
  • 项目类别:
Core-A Administative
核心A行政管理
  • 批准号:
    8105266
  • 财政年份:
    2010
  • 资助金额:
    $ 100.05万
  • 项目类别:
Inhibition, Oscillations and Information Processing in Schizophrenia
精神分裂症的抑制、振荡和信息处理
  • 批准号:
    8061036
  • 财政年份:
    2010
  • 资助金额:
    $ 100.05万
  • 项目类别:
Core-B Clinical Services and Diagnostics
核心 B 临床服务和诊断
  • 批准号:
    8105267
  • 财政年份:
    2010
  • 资助金额:
    $ 100.05万
  • 项目类别:
Inhibition, Oscillations and Information Processing in Schizophrenia
精神分裂症的抑制、振荡和信息处理
  • 批准号:
    7929309
  • 财政年份:
    2009
  • 资助金额:
    $ 100.05万
  • 项目类别:

相似海外基金

Kilohertz volumetric imaging of neuronal action potentials in awake behaving mice
清醒行为小鼠神经元动作电位的千赫兹体积成像
  • 批准号:
    10515267
  • 财政年份:
    2022
  • 资助金额:
    $ 100.05万
  • 项目类别:
Signal processing in horizontal cells of the mammalian retina – coding of visual information by calcium and sodium action potentials
哺乳动物视网膜水平细胞的信号处理 â 通过钙和钠动作电位编码视觉信息
  • 批准号:
    422915148
  • 财政年份:
    2019
  • 资助金额:
    $ 100.05万
  • 项目类别:
    Research Grants
CAREER: Resolving action potentials and high-density neural signals from the surface of the brain
职业:解析来自大脑表面的动作电位和高密度神经信号
  • 批准号:
    1752274
  • 财政年份:
    2018
  • 资助金额:
    $ 100.05万
  • 项目类别:
    Continuing Grant
Development of Nanosheet-Based Wireless Probes for Multi-Simultaneous Monitoring of Action Potentials and Neurotransmitters
开发基于纳米片的无线探针,用于同时监测动作电位和神经递质
  • 批准号:
    18H03539
  • 财政年份:
    2018
  • 资助金额:
    $ 100.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Population Imaging of Action Potentials by Novel Two-Photon Microscopes and Genetically Encoded Voltage Indicators
通过新型双光子显微镜和基因编码电压指示器对动作电位进行群体成像
  • 批准号:
    9588470
  • 财政年份:
    2018
  • 资助金额:
    $ 100.05万
  • 项目类别:
Enhanced quantitative imaging of compound action potentials in multi-fascicular peripheral nerve with fast neural Electrical Impedance Tomography enabled by 3D multi-plane softening bioelectronics
通过 3D 多平面软化生物电子学实现快速神经电阻抗断层扫描,增强多束周围神经复合动作电位的定量成像
  • 批准号:
    10009724
  • 财政年份:
    2018
  • 资助金额:
    $ 100.05万
  • 项目类别:
Enhanced quantitative imaging of compound action potentials in multi-fascicular peripheral nerve with fast neural Electrical Impedance Tomography enabled by 3D multi-plane softening bioelectronics
通过 3D 多平面软化生物电子学实现快速神经电阻抗断层扫描,增强多束周围神经复合动作电位的定量成像
  • 批准号:
    10467225
  • 财政年份:
    2018
  • 资助金额:
    $ 100.05万
  • 项目类别:
Fast high-resolution deep photoacoustic tomography of action potentials in brains
大脑动作电位的快速高分辨率深度光声断层扫描
  • 批准号:
    9423398
  • 财政年份:
    2017
  • 资助金额:
    $ 100.05万
  • 项目类别:
NeuroGrid: a scalable system for large-scale recording of action potentials from the brain surface
NeuroGrid:用于大规模记录大脑表面动作电位的可扩展系统
  • 批准号:
    9357409
  • 财政年份:
    2016
  • 资助金额:
    $ 100.05万
  • 项目类别:
Noval regulatory mechanisms of axonal action potentials
轴突动作电位的新调节机制
  • 批准号:
    16K07006
  • 财政年份:
    2016
  • 资助金额:
    $ 100.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了